FABP5

Fatty acid-binding protein 5 · Q01469 · FABP5 on Sugi Atlas →

116,935 patent compounds predicted against FABP5, 82,692 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL67480 SCHEMBL67480 0.47 4/20
SCHEMBL44677 SCHEMBL44677 0.59 3/20
SCHEMBL44676 SCHEMBL44676 0.56 3/20
SCHEMBL27547 SCHEMBL27547 0.54 3/20
SCHEMBL37865 SCHEMBL37865 0.53 3/20
SCHEMBL68446 SCHEMBL68446 0.50 3/20
Alpha-Naphthylacetate Alpha-Naphthylacetate (SCHEMBL76633) 0.50 3/20
SCHEMBL47693 SCHEMBL47693 0.49 3/20
SCHEMBL68437 SCHEMBL68437 0.47 3/20
SCHEMBL60495 SCHEMBL60495 0.46 3/20
SCHEMBL97613 SCHEMBL97613 0.46 3/20
SCHEMBL87486 SCHEMBL87486 0.43 3/20
SCHEMBL73044 SCHEMBL73044 0.43 3/20
SCHEMBL7764 SCHEMBL7764 0.42 3/20
SCHEMBL12719 SCHEMBL12719 0.42 3/20
SCHEMBL8131 SCHEMBL8131 0.41 3/20
SCHEMBL28050 SCHEMBL28050 0.41 3/20
SCHEMBL67486 SCHEMBL67486 0.36 3/20
Tolfenamic Acid Tolfenamic Acid (SCHEMBL25190) 0.66 2/20
Lobenzarit Lobenzarit (SCHEMBL7935) 0.55 2/20

Clinical trials — most relevant to FABP5 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Tubular Markers in Response to Saxagliptin Therapy PHASE4COMPLETED
Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH) PHASE4COMPLETED
Prediction of NEC With Urinary iFABP PHASE2WITHDRAWN
Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors nanNOT_YET_RECRUITING
HIIT in Sedentary Obese Adults: Effects on Metabolic Risk, Body Composition, and FABP4 nanRECRUITING
Plasma i-FABP as Predictor for Irreversible Bowel Ischemia nanUNKNOWN
Biomarkers and Risk Scores for Risk Stratification of Unstable Angina nanUNKNOWN
Inflamation, Gut Leakage, Iron Status After 6000m Ergometer Test in Elite Rowers. nanCOMPLETED
Diagnostic Value of Heart-Fatty Acid Binding Protein and Ischemia Modified Albumin as Biochemical Markers on Non ST Segment Elevation Acute Coronary Syndrome at the Emergency Room. nanCOMPLETED
Potential Association of a Common L-FABP Polymorphism With Lipid-induced Hepatic Insulin Resistance nanCOMPLETED
Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD nanCOMPLETED
The Usefulness of Growth Differentiation Factor 15 (GDF-15) for Risk Stratification in Cardiac Surgery nanCOMPLETED
Ramadan Fasting, Microbiota and FABP4 nanUNKNOWN
Effect of Obstructive Sleep Apnea on Central Blood Pressure and Kidney and Endothelial Function nanUNKNOWN
Gut, Inflammation and Nutrition in Adult Patients After Fontan Operation nanCOMPLETED
Biomarkers for Postoperative Myocardial Infarction in Cardiac Surgery. nanWITHDRAWN
Modified Perfusion for Neonatal Aortic Arch Reconstruction nanCOMPLETED
N/LP Ratio as Predictor of Mortality in Septic AKI Patients nanUNKNOWN
Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients nanRECRUITING
Placebo Controlled Study for Characterisation of Immunological Effects and Safety of Active O2 nanCOMPLETED
The Detrimental Course of Acute Intestinal Ischemia nanUNKNOWN
Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters. nanCOMPLETED
I-FABP as a Predictor of Gastrointestinal Involvement in Pediatric IgA Vasculitis nanRECRUITING
Searching Biomarkers of Acute Intestinal Ischemic Injuries nanRECRUITING
Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM) nanCOMPLETED
BATokines as Biomarkers of Brown Fat in Humans nanACTIVE_NOT_RECRUITING
Enterocyte Injury and Acute Gastrointestinal Dysfunction in Critical Illness nanNOT_YET_RECRUITING
Exploring the Role of Adipocyte Fatty Acid Binding Protein in the Association of Obstructive Sleep Apnea and Metabolic Dysfunction nanCOMPLETED
Persistent Multiorgan Failure in Intensive Care Units nanCOMPLETED
The Effect of Blood Flow Restriction (Bfr) Exercise on Acute Systemic Myokine Levels in Healthy Trained Men nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a FABP5 binder may also engage these)

ProteinNameSimilarity
P55053 0.999 P55053 →
P55052 0.998 P55052 →
Q05816 0.998 Q05816 →
P10790 0.996 P10790 →
FABP3 Fatty acid-binding protein, heart 0.995 landscape →
Q4TZH2 0.995 Q4TZH2 →
P80049 0.994 P80049 →
FABP4 Fatty acid-binding protein, adipocyte 0.994 landscape →
O02772 0.993 O02772 →
P11404 0.993 P11404 →
Q05423 0.993 Q05423 →
Q865F7 0.992 Q865F7 →
P51880 0.992 P51880 →
P24526 0.991 P24526 →
A6YLM6 0.991 A6YLM6 →
A0A0K0MJN3 0.991 A0A0K0MJN3 →
Q99P60 0.991 Q99P60 →
O97788 0.991 O97788 →
P70623 0.990 P70623 →
Q99P61 0.990 Q99P61 →
Q0Z7S8 0.990 Q0Z7S8 →
P48035 0.989 P48035 →
O13008 0.989 O13008 →
Q66RP5 0.989 Q66RP5 →
P04117 0.989 P04117 →
P02690 0.989 P02690 →
Q09139 0.989 Q09139 →
O45035 0.989 O45035 →
P07483 0.989 P07483 →
C4N147 0.989 C4N147 →